查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
庞贝病全球市场规模调查，按给药途径，按治疗类型（底物减少疗法，酵素替代疗法，伴侣替代疗法，支持性护理），用户，地区预测 2022-2028
市场调查报告书
商品编码
1119090

庞贝病全球市场规模调查，按给药途径，按治疗类型（底物减少疗法，酵素替代疗法，伴侣替代疗法，支持性护理），用户，地区预测 2022-2028

Global Pompe Diseases Market Size study, by Route of Administration, By Treatment Type (Substrate Reduction Therapy, Enzyme Replacement Therapy, Chaperone-Advanced Replacement Therapy, Supportive Care), By End User and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2022-2028 年预测期间的 5%。

庞贝病是一种影响身体细胞中称为糖原的复杂碳水化合物积累的疾病。它是遗传遗传的，会导致一些组织和器官，尤其是肌肉，积累糖原并停止正常运作。据估计，美国每 40,000 人中就有 1 人患有庞贝病。市场增长由新药推出、长期疗法的持续采用以及酵素替代疗法领域的发展增加等关键因素推动。例如，根据 2021 年 11 月发表在 Journal of Molecules 上的一篇题为“Pharmacological Chaperone Therapy for Pompe disease”的论文，与 rhGAA 一起静脉内给药的酵素替代疗法（ERT）是 Pompe 病的唯一治疗方法。得到正式认可的。由于 ERT 的缺点，研究人员正在寻找新的治疗方法，这是美国食品和药物管理局批准的唯一药物。此外，2021 年 8 月，酵素替代疗法 Aval 葡萄糖甘酵素 Alfa 获得美国食品药品监督管理局 (FDA) 的批准，用于治疗 1 岁及以上的迟发性庞贝病。此外，针对庞贝病的新兴免疫疗法将在未来几年带来丰厚的市场机会。然而，高昂的治疗成本将阻碍 2022-2028 年预测期内的市场增长。

庞贝病全球市场研究考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于新药的推出和研发支出的增加，北美在整体市场份额方面处于领先地位。然而，由于患者对罕见病的认识不断提高以及该地区庞贝病的患病率上升，预计亚太地区将增长最快。

本报告中包括的主要市场进入者是：

  • Amicus Therapeutics
  • CENTOGENE AG
  • Valerion 疗法
  • 安斯泰来製药
  • EpiVax, Inc.
  • 环氧乙烷
  • 赛诺菲
  • AVROBIO, Inc.
  • 基因松
  • Sangamo Therapeutics

本研究的目的是确定近年来各个细分市场和国家/地区的市场规模，并预测未来八年的价值。本报告旨在捕捉所调查的每个地区和国家的行业的定性和定量方面。此外，它还提供了有关关键方面的详细信息，例如定义市场未来增长的驱动因素和挑战。此外，该报告还应纳入微观市场中可供利益相关者投资的可用机会，以及对竞争格局和主要参与者的应用产品的深入分析。市场的详细细分和子细分如下所述。

按给药途径：

口头

肠胃外给药

按治疗类型

底物减少疗法 (SRT)

酵素替代疗法 (ERT)

伴侣替代疗法 (CART)

支持性护理

按最终用户

医院

诊断中心

门诊手术中心

杂项

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考虑的年份是：

实际年份 - 2018 年、2019 年、2020 年

2021 年基准年

预测期 - 2022 年 至 2028 年

本报告的目标受众是全球庞贝病市场。

主要咨询公司和顾问

大公司、中型公司、中小企业

风险投资

增值经销商 (VAR)

第三方知识提供者

投资银行家

投资者

内容

第 1 章执行摘要

  • 市场快照
  • 2020-2028 年全球市场和细分市场估计和预测
    • 按地区分列的庞贝病市场：2020-2028
    • 庞贝病市场（按给药途径）：2020-2028
    • 按治疗类型划分的庞贝病市场：2020-2028
    • 庞贝病市场（按最终用户）：2020-2028
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章庞贝病全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第三章庞贝病全球市场动态

  • 庞贝病市场影响分析（2020-2028）
    • 市场驱动力
      • 新药上市，长效疗法持续推广
      • 在酵素替代疗法领域的发展增加
    • 市场挑战
      • 治疗费用高
    • 市场机会
      • 一种新的庞贝病免疫治疗方法

第四章全球庞贝病市场行业分析

  • 波特的 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
    • 波特 5 力模型的未来方法（2018-2028）
  • PEST 分析
    • 政治
    • 经济
    • 社交
    • 技术
  • 招商引资模式
  • 分析师的结论和建议
  • 热门投资机会
  • 制胜法宝

第 5 章风险评估：COVID-19 的影响

    • 评估 COVID-19 对行业的整体影响
    • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章。庞贝病的全球市场：按给药途径

  • 市场快照
  • 全球庞贝病市场：按给药途径、性能潜力分析
  • 2018-2028 年世界庞贝病市场、按管理途径估计和预测
  • 庞贝病市场，细分分析
    • 口服剂
    • 肠胃外给药

第 7 章：庞贝病全球市场：按治疗类型分类

  • 市场快照
  • 庞贝病全球市场：按治疗类型进行的性能潜力分析
  • 2018-2028 年按治疗类型分列的庞贝病全球市场、估计和预测
  • 庞贝病市场，细分分析
    • 底物减少疗法 (SRT)
    • 酵素替代疗法 (ERT)
    • 伴侣替代疗法 (CART)
    • 支持性护理

第 8 章。庞贝病全球市场：按最终用户分类

  • 市场快照
  • 庞贝病全球市场：最终用户的性能潜力分析
  • 2018-2028 年按最终用户分列的庞贝病全球市场、估计和预测
  • 庞贝病市场，细分分析
    • 医院
    • 诊断中心
    • 门诊手术中心
    • 其他

第 9 章。庞贝病全球市场：区域分析

  • 庞贝病市场：按地区划分的市场快照
  • 北美
    • 美国
      • 2018-2028 年按给药途径进行的估计和预测
      • 按治疗类型划分的估计和预测，2018-2028 年
      • 2018-202 年最终用户的估计和预测
    • 加拿大
  • 欧洲庞贝病市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太庞贝病市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲庞贝病市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Sangamo Therapeutics
      • 主要信息
      • 概览
      • 财务（仅在可以提供数据的情况下）
      • 给药途径总结
      • 近期发展状况
    • Amicus Therapeutics
    • CENTOGENE AG
    • Valerion Therapeutics
    • Astellas Pharma
    • EpiVax, Inc
    • Oxyrane
    • Sanofi
    • AVROBIO, Inc.
    • Genethon

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场估算
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Pompe Diseases Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2028. Pompe disease is a disorder affected by the buildup of a complex sugar called glycogen in the body's cells. It is inherited genetically, and the buildup of glycogen in some tissues and organs, especially muscles, makes them less able to operate normally. In the United States, one in 40,000 people have Pompe disease. The market growth is driven by key factors such as launch of novel drugs and the continued uptake of long-term therapies and increasing development in the field of enzyme replacement therapies. For instance, Enzyme replacement therapy (ERT), which involves giving rhGAA intravenously, is the only treatment for Pompe illness that has been approved, according to a paper titled "Pharmacological Chaperone Therapy for Pompe Disease" that was published in the Journal of Molecules in November 2021. Researchers are looking for novel treatments because of the shortcomings of ERT. which is the sole medication acknowledged by the US Food and Drug Administration. Furthermore, in August 2021, Enzyme Replacement therapy "Aval glucosidase Alfa" has been approved by United State of Food and Drug Administration, for the patient aged 1 year and older with late onset pompe disease. Moreover, emerging immunotherapeutic approaches for Pompe disease create lucrative opportunity for the market in upcoming years. However, high Treatment Cost impedes the growth of the market over the forecast period of 2022-2028

The key regions considered for the global Pompe Diseases Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to rising launches of novel drugs and growing research and development expenditure. However, Asia Pacific is expected to be the fastest growing region due to growing awareness among patients regarding rare disorders and increase in the prevalence of pompe disease in the region.

Major market players included in this report are:

Amicus Therapeutics

CENTOGENE AG

Valerion Therapeutics

Astellas Pharma

EpiVax, Inc

Oxyrane

Sanofi

AVROBIO, Inc.

Genethon

Sangamo Therapeutics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

Oral

Parenteral

By Treatment Type:

Substrate Reduction Therapy (SRT)

Enzyme Replacement Therapy (ERT)

Chaperone-Advanced Replacement Therapy (CART)

Supportive Care

By End User:

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Pompe Diseases Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Pompe Disease Market, by region, 2020-2028 (USD Million)
    • 1.2.2. Pompe Disease Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.3. Pompe Disease Market, by Treatment Type, 2020-2028 (USD Million)
    • 1.2.4. Pompe Disease Market, by End User, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pompe Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pompe Disease Market Dynamics

  • 3.1. Pompe Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Launch of novel drugs and the continued uptake of long-term therapies
      • 3.1.1.2. Increasing development in the field of enzyme replacement therapies
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Emerging immunotherapeutic approaches for Pompe disease

Chapter 4. Global Pompe Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Pompe Disease Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Pompe Disease Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Pompe Disease Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
  • 6.4. Pompe Disease Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Parenteral

Chapter 7. Global Pompe Disease Market, by Treatment Type

  • 7.1. Market Snapshot
  • 7.2. Global Pompe Disease Market by Treatment Type, Performance - Potential Analysis
  • 7.3. Global Pompe Disease Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)
  • 7.4. Pompe Disease Market, Sub Segment Analysis
    • 7.4.1. Substrate Reduction Therapy (SRT)
    • 7.4.2. Enzyme Replacement Therapy (ERT)
    • 7.4.3. Chaperone-Advanced Replacement Therapy (CART)
    • 7.4.4. Supportive Care

Chapter 8. Global Pompe Disease Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Pompe Disease Market by End User, Performance - Potential Analysis
  • 8.3. Global Pompe Disease Market Estimates & Forecasts by End User, 2018-2028 (USD Million)
  • 8.4. Pompe Disease Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others

Chapter 9. Global Pompe Disease Market, Regional Analysis

  • 9.1. Pompe Disease Market, Regional Market Snapshot
  • 9.2. North America Pompe Disease Market
    • 9.2.1. U.S. Pompe Disease Market
      • 9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End User breakdown estimates & forecasts, 2018-202
    • 9.2.2. Canada Pompe Disease Market
  • 9.3. Europe Pompe Disease Market Snapshot
    • 9.3.1. U.K. Pompe Disease Market
    • 9.3.2. Germany Pompe Disease Market
    • 9.3.3. France Pompe Disease Market
    • 9.3.4. Spain Pompe Disease Market
    • 9.3.5. Italy Pompe Disease Market
    • 9.3.6. Rest of Europe Pompe Disease Market
  • 9.4. Asia-Pacific Pompe Disease Market Snapshot
    • 9.4.1. China Pompe Disease Market
    • 9.4.2. India Pompe Disease Market
    • 9.4.3. Japan Pompe Disease Market
    • 9.4.4. Australia Pompe Disease Market
    • 9.4.5. South Korea Pompe Disease Market
    • 9.4.6. Rest of Asia Pacific Pompe Disease Market
  • 9.5. Latin America Pompe Disease Market Snapshot
    • 9.5.1. Brazil Pompe Disease Market
    • 9.5.2. Mexico Pompe Disease Market
  • 9.6. Rest of The World Pompe Disease Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sangamo Therapeutics
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Route of Administration Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Amicus Therapeutics
    • 10.2.3. CENTOGENE AG
    • 10.2.4. Valerion Therapeutics
    • 10.2.5. Astellas Pharma
    • 10.2.6. EpiVax, Inc
    • 10.2.7. Oxyrane
    • 10.2.8. Sanofi
    • 10.2.9. AVROBIO, Inc.
    • 10.2.10. Genethon

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pompe Disease Market, report scope
  • TABLE 2. Global Pompe Disease Market estimates & forecasts by region 2018-2028 (USD Million)
  • TABLE 3. Global Pompe Disease Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 4. Global Pompe Disease Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)
  • TABLE 5. Global Pompe Disease Market estimates & forecasts by End User 2018-2028 (USD Million)
  • TABLE 6.
  • TABLE 7. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Pompe Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Pompe Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Pompe Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Pompe Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Pompe Disease Market
  • TABLE 57. List of primary sources, used in the study of global Pompe Disease Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Pompe Disease Market, research methodology
  • FIG 2. Global Pompe Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Pompe Disease Market, key trends 2021
  • FIG 5. Global Pompe Disease Market, growth prospects 2022-2028
  • FIG 6. Global Pompe Disease Market, porters 5 force model
  • FIG 7. Global Pompe Disease Market, pest analysis
  • FIG 8. Global Pompe Disease Market, value chain analysis
  • FIG 9. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Pompe Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Pompe Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Pompe Disease Market 2018 & 2028 (USD Million)
  • FIG 19. Global Pompe Disease Market, company market share analysis (2021)